ArticleCancer2012

Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.

David M Hyman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.